Basic Information
Portocanna Aims to Become Europe's Leading Medical Cannabis ProcessorPortocanna aims to become Europe's leading medical cannabis processor. The company owns a 3,000-square-meter EU GMP-certified facility, an in-house R&D laboratory, and the largest cannabis logistics center in the EU, supported by a highly skilled and experienced team. Following the successful launch of medical cannabis products in Germany and the UK, Portocanna is preparing to introduce its products to the Portuguese market, focusing on expanding its portfolio in these key markets. Additionally, the company is actively pursuing growth opportunities in other European regions. With 25 proprietary cannabis strains developed and registered, along with significant investment in R&D, Portocanna is pioneering innovative delivery methods.